Bruker Daltonics announced today the establishment of a long-term
collaborative programme for developing both applications and fundamental
instrument technology in the area of extreme resolution mass
spectrometry.
Building on over 14 years of experience in high performance mass
spectrometry at the Department of Chemistry at Warwick, the University’s
recent acquisition of both the new Bruker solariX™
12 Tesla FTMS system and the maXis™
UHR-TOF system again puts the department at the forefront of technology
for high performance mass spectrometry. At the core of the new
instruments are dramatic improvements, up to an order of magnitude, in
previous performance standards. These advances help address the
University’s most challenging analyses including very complex mixtures
in applications such as chemistry, medicinal discovery, protein
interactions and petroleomics.
The collaboration is unusual in that it embraces not only topical
applications innovation but also fundamental instrument development, the
latter headed by Warwick Professor Peter O’Connor, who recently arrived
from Boston University, and is one of the world’s most accomplished FTMS
instrument development scientists. “We are very excited to be able to
benefit from Peter’s ideas, and have arranged a technical fast-track for
his developments to appear in our FTMS products,” commented Dr. Michael
Schubert, Executive Vice President for R&D at Bruker Daltonics.
Professor Peter Sadler, Head of Chemistry at the University, whose
research interests focus on metals in biology and medicine, the design
and mechanism of action of metallodrugs, especially the role of proteins
in metal-induced signal transduction said: “In my field state-of-the-art
analysis of metal speciation holds the key to major breakthroughs in
understanding both how metal ions control natural biological processes,
and how metal complexes can be designed as novel therapeutic agents.
Moreover, this new Bruker mass spec equipment, and the associated
collaboration, will allow our newly established EPSRC Warwick Centre for
Analytical Science to compete strongly at the forefront of the field.”
“We are delighted that Professors Sadler and O’Connor, who both have
outstanding track records in the design and implementation of
cutting-edge mass spectrometry, have chosen Bruker as a supplier and
collaborative partner. It is especially gratifying to see real
instrument development receiving such an energetic renewal in the UK,”
commented Dr. Ian Sanders, Executive Vice President for Worldwide Sales
and Marketing at Bruker Daltonics.
The solariX
and maXis
will be highlighted at the 18th International Mass
Spectrometry Conference (www.imsc-bremen-2009.de)
in Bremen, Germany from August 30 to September 4, 2009. For more
information on IMSC 2009 and related Bruker Daltonics activities, please
visit www.bdal.com/imsc.
ABOUT BRUKER DALTONICS
For more information about Bruker Daltonics and Bruker Corporation
(NASDAQ: BRKR), please visit www.bdal.com
and www.bruker.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6008377〈en
Bruker Daltonics Ltd
Dr. Annabelle McIntyre, +44 2476855200
annabelle.mcintyre@daltonics.bruker.co.uk
